KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $793.8 million.

  • Opko Health's Shares Outstanding (Weighted Average) rose 13.82% to $793.8 million in Q3 2025 from the same period last year, while for Jun 2025 it was $793.1 million, marking a year-over-year increase of 13.78%. This contributed to the annual value of $682.5 million for FY2024, which is 11.72% down from last year.
  • According to the latest figures from Q3 2025, Opko Health's Shares Outstanding (Weighted Average) is $793.8 million, which was up 0.09% from $793.1 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Shares Outstanding (Weighted Average) ranged from a high of $793.8 million in Q3 2025 and a low of $670.0 million during Q1 2021.
  • For the 3-year period, Opko Health's Shares Outstanding (Weighted Average) averaged around $738.5 million, with its median value being $772.7 million (2023).
  • In the last 5 years, Opko Health's Shares Outstanding (Weighted Average) fell by 11.72% in 2024 and then increased by 13.82% in 2025.
  • Over the past 5 years, Opko Health's Shares Outstanding (Weighted Average) (Quarterly) stood at $681.3 million in 2021, then grew by 13.41% to $772.7 million in 2022, then climbed by 0.05% to $773.1 million in 2023, then fell by 11.72% to $682.5 million in 2024, then climbed by 13.82% to $793.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $793.8 million for Q3 2025, versus $793.1 million for Q2 2025 and $671.6 million for Q1 2025.